18 European techbio startups to watch — according to investors
The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara
AI and computational biology transforming chronic liver disease research
‘I wanted to do something in health but I didn’t want to be a doctor’: Ochre Bio founder Jack O’Meara
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
Five Spatial Genomics Up-and-Coming Firms
Jeremy Hunt’s R&D shake-up divides UK small businesses
Oxford biotech raises funds to make RNA treatments for liver disease
